Literature DB >> 31413096

Genomics of therapy-related myeloid neoplasms.

Teodora Kuzmanovic1, Bhumika J Patel1, Srinivasa R Sanikommu1, Yasunobu Nagata1, Hassan Awada1, Cassandra M Kerr1, Bartlomiej P Przychodzen1, Babal K Jha1, Devendra Hiwase2, Deepak Singhal2, Anjali S Advani3, Aziz Nazha3, Aaron T Gerds3, Hetty E Carraway3, Mikkael A Sekeres3, Sudipto Mukherjee3, Jaroslaw P Maciejewski4,3, Tomas Radivoyevitch1,5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31413096      PMCID： PMC7049337          DOI： 10.3324/haematol.2019.219352

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   11.047


× No keyword cloud information.
  14 in total

1.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.

Authors:  Catherine C Coombs; Ahmet Zehir; Sean M Devlin; Ashwin Kishtagari; Aijazuddin Syed; Philip Jonsson; David M Hyman; David B Solit; Mark E Robson; José Baselga; Maria E Arcila; Marc Ladanyi; Martin S Tallman; Ross L Levine; Michael F Berger
Journal:  Cell Stem Cell       Date:  2017-08-10       Impact factor: 24.633

Review 2.  Therapy-related myeloid neoplasms: when genetics and environment collide.

Authors:  Megan E McNerney; Lucy A Godley; Michelle M Le Beau
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

3.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.

Authors:  Florian Zink; Simon N Stacey; Gudmundur L Norddahl; Michael L Frigge; Olafur T Magnusson; Ingileif Jonsdottir; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Sigurjon A Gudjonsson; Julius Gudmundsson; Jon G Jonasson; Laufey Tryggvadottir; Thorvaldur Jonsson; Agnar Helgason; Arnaldur Gylfason; Patrick Sulem; Thorunn Rafnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Gisli Masson; Augustine Kong; Kari Stefansson
Journal:  Blood       Date:  2017-05-08       Impact factor: 22.113

Review 4.  DNA adducts from chemotherapeutic agents.

Authors:  P D Lawley; D H Phillips
Journal:  Mutat Res       Date:  1996-08-17       Impact factor: 2.433

5.  Mutation analysis of therapy-related myeloid neoplasms.

Authors:  Takahiro Nishiyama; Yuichi Ishikawa; Naomi Kawashima; Akimi Akashi; Yoshiya Adachi; Hikaru Hattori; Yoko Ushijima; Hitoshi Kiyoi
Journal:  Cancer Genet       Date:  2018-03-08

6.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

7.  Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays.

Authors:  Catherine C Coombs; Nancy K Gillis; Xianming Tan; Jonathan S Berg; Markus Ball; Maria E Balasis; Nathan D Montgomery; Kelly L Bolton; Joel S Parker; Tania E Mesa; Sean J Yoder; Michele C Hayward; Nirali M Patel; Kristy L Richards; Christine M Walko; Todd C Knepper; John T Soper; Jared Weiss; Juneko E Grilley-Olson; William Y Kim; H Shelton Earp; Ross L Levine; Elli Papaemmanuil; Ahmet Zehir; D Neil Hayes; Eric Padron
Journal:  Clin Cancer Res       Date:  2018-06-04       Impact factor: 12.531

8.  Age-related mutations associated with clonal hematopoietic expansion and malignancies.

Authors:  Mingchao Xie; Charles Lu; Jiayin Wang; Michael D McLellan; Kimberly J Johnson; Michael C Wendl; Joshua F McMichael; Heather K Schmidt; Venkata Yellapantula; Christopher A Miller; Bradley A Ozenberger; John S Welch; Daniel C Link; Matthew J Walter; Elaine R Mardis; John F Dipersio; Feng Chen; Richard K Wilson; Timothy J Ley; Li Ding
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

9.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Siddhartha Jaiswal; Pradeep Natarajan; Alexander J Silver; Christopher J Gibson; Alexander G Bick; Eugenia Shvartz; Marie McConkey; Namrata Gupta; Stacey Gabriel; Diego Ardissino; Usman Baber; Roxana Mehran; Valentin Fuster; John Danesh; Philippe Frossard; Danish Saleheen; Olle Melander; Galina K Sukhova; Donna Neuberg; Peter Libby; Sekar Kathiresan; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245

10.  Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors:  Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal:  Nature       Date:  2014-12-08       Impact factor: 49.962
View more
  9 in total

Review 1.  Lower risk but high risk.

Authors:  Amy E DeZern
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.

Authors:  Alexandra Higgins; Mithun Vinod Shah
Journal:  Genes (Basel)       Date:  2020-07-06       Impact factor: 4.096

Review 3.  The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications.

Authors:  Hassan Awada; Bicky Thapa; Valeria Visconte
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

4.  Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case series.

Authors:  Jennifer L Oliveira; Patricia T Greipp; Aruna Rangan; Aminah Jatoi; Phuong L Nguyen
Journal:  Blood Cancer J       Date:  2022-01-25       Impact factor: 11.037

5.  Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.

Authors:  Anand Ashwin Patel; Alexandra E Rojek; Michael W Drazer; Howard Weiner; Lucy A Godley; Michelle M Le Beau; Richard A Larson
Journal:  Blood Adv       Date:  2021-10-26

Review 6.  Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.

Authors:  Goodwin G Jinesh; Andrew S Brohl
Journal:  Signal Transduct Target Ther       Date:  2022-08-23

7.  Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms.

Authors:  Mithun Vinod Shah; Rakchha Chhetri; Ruchita Dholakia; Chung H Kok; Naseema Gangat; Hassan B Alkhateeb; Aref Al-Kali; Mrinal M Patnaik; Anmol Baranwal; Patricia T Greipp; Rong He; Kebede H Begna; Ing Soo Tiong; Andrew H Wei; Devendra Hiwase
Journal:  Am J Hematol       Date:  2022-05-27       Impact factor: 13.265

Review 8.  Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Cancers (Basel)       Date:  2020-08-26       Impact factor: 6.639

Review 9.  Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies.

Authors:  Ibolya Czegle; Austin L Gray; Minjing Wang; Yan Liu; Jun Wang; Edina A Wappler-Guzzetta
Journal:  Life (Basel)       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.